(Q38577688)

4 September 2017

Type III interferons (IFNs): Emerging Master Regulators of Immunity (English)

1 reference

4 September 2017

Ioanna E Galani

1

1 reference

4 September 2017

Ourania Koltsida

series ordinal

2

1 reference

4 September 2017

Evangelos Andreakos

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

Advances in Experimental Medicine and Biology

4 September 2017

1 reference

4 September 2017

850

1 reference

4 September 2017

1-15

1 reference

Antitumor activity of type I and type III interferons in BNL hepatoma model

4 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-25: the missing link between allergy, viral infection, and asthma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

The management of side-effects during therapy for hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Role of deficient type III interferon-λ production in asthma exacerbations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Human natural interferon-alpha producing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-lambda family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Molecular cloning, expression, and characterization of chicken IFN -lambda

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Identification of the zebrafish IFN receptor: implications for the origin of the vertebrate IFN system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Regulation of apoptosis by type III interferons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-28 elicits antitumor responses against murine fibrosarcoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Diverse intracellular pathogens activate type III interferon expression from peroxisomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFN-lambda determines the intestinal epithelial antiviral host defense

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Lambda interferon inhibits hepatitis B and C virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Interferome v2.0: an updated database of annotated interferon-regulated genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Antitumor activity of IFN-lambda in murine tumor models

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IL-28, IL-29 and their class II cytokine receptor IL-28R

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

The nature of the principal type 1 interferon-producing cells in human blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

The role of transposable elements in the regulation of IFN-lambda1 gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Activation of toll-like receptor-3 induces interferon-lambda expression in human neuronal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-15774-0_1

10.1007/978-3-319-15774-0_1

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference